selective serotonin re-uptake inhibitors

selective serotonin re-uptake inhibitors (SSRIs)

A range of drugs that act at the clefts of synapses in the brain preventing released SEROTONIN from being removed and thus increasing its action as a NEUROTRANSMITTER. These drugs are used to treat depression, anxiety, panic disorders, agoraphobia, bulimia, obsessive-compulsive disorders and post-traumatic stress disorder syndrome. Generic names are CITALOPRAM, FLUOXETINE, FLUVOXAMINE, PAROXETINE, and SERTRALINE. Other drugs (e.g. VENLAFAXINE) are specific promoters of the action of both serotonin and noradrenaline and are termed selective noradrenaline and serotonin inhibitors (SNRIs). Doubts have been expressed as to the specificity of some of the drugs in this group for treating certain of these conditions. Brand names can be found in the generic entries.
References in periodicals archive ?
Selective serotonin re-uptake inhibitors (SSRIs) have been used for treatment of anxiety and depression [3].
Commonly prescribed medications for GAD include benzodiazepines and antidepressants such as selective serotonin re-uptake inhibitors, and whilst effective, they can be associated with adverse side effects.
Low levels of central serotonin have been related to the state of depression, and 5-HT is the major target of newer antidepressant drugs, such as selective serotonin re-uptake inhibitors. Neurons and platelets display structural and functional similarities, so that the latter have been proposed as a peripheral model of central functions.
Reports have surfaced on the deleterious effects of two commonly used drugs on a developing baby - paracetamol and antidepressant SSRIs (Selective serotonin re-uptake inhibitors).
Emma, by email A Taking antidepressants such as Prozac and other SSRIs (selective serotonin re-uptake inhibitors) can affect your sex drive and make people feel Have your emotional problems sorted by our expert Marisa switched off from their emotions.
GBI Research, the leading business intelligence provider, has released its latest research, Antidepressants Market to 2018 Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives, which provides insights into the antidepressants market until 2018.
Serotonin is the target of the popular antidepressants known as SSRIs, or selective serotonin re-uptake inhibitors, which prolong the effect of serotonin in the brain by slowing its absorption by brain cells.
A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.
Newer "selective serotonin re-uptake inhibitors" - including Prozac - rose by 5.6 per cent in the last year.
(5) However, despite some support through the efficacy of such medications as tricyclic antidepressants (TCA) and selective serotonin re-uptake inhibitors (SSRIs), this theory remains at best incomplete.
Sertraline belongs to the class of anti-depressant drugs known as selective serotonin re-uptake inhibitors and is used in the treatment of depression, obsessive compulsive disorder - an urge to continually repeat the same action - and post-traumatic stress disorder in women.

Full browser ?